Immunic Executes 1-for-10 Reverse Split, Boosts Share Price to $9.76
Immunic executed a 1-for-10 reverse stock split on April 27, reducing outstanding shares from approximately 136 million to about 13.6 million to satisfy securities agreement obligations. Post-split, the share price stands at $9.76, yielding a market capitalization of about $96.3 million.
1. Reverse Split Execution
On April 27, 2026, Immunic executed a 1-for-10 reverse stock split approved by stockholders on April 14. This corporate action reduces ten pre-split shares into one post-split share to satisfy a recent securities agreement and maintain compliance with Nasdaq Capital Market listing requirements.
2. Share Reduction and Market Capitalization
The reverse split cut outstanding shares from approximately 136 million to about 13.6 million, boosting the post-split share price to $9.76 and setting the company’s market capitalization at roughly $96.3 million.
3. Trading Activity and Price Movement
In trading after the split, the share price rose 10.9%, moving within a daily range of $8.50 to $10.30 on a volume of about 290,162 shares. Over the past 12 months, the adjusted share price has fluctuated between $5.06 and $15.10.